Introduction

Marine natural resources have continued to provide structurally and biologically novel compounds, some of which are promising leads for the development of new drugs.1, 2, 3 Marine microorganisms, especially marine-derived fungi, have been attractive and important sources of pharmacologically active secondary metabolites.4, 5, 6 Marine fungal metabolites, possessing unique structures and biological properties, are expected to become candidates for advanced medicines and biochemical reagents.4, 5, 6

In the course of our search for useful bioactive substances from marine microorganisms, the marine-derived Penicillium sp. TPU1271 was found to produce various types of secondary metabolites. HPLC separation from a culture broth of strain TPU1271 led to the isolation of an epimeric pair of polyketides containing α-pyrone and the tetrahydrofuran rings, penicyrones A (1) and B (2) (Figure 1), as well as nine known compounds: verrucosidin (3),7, 8, 9, 10, 11 fructigenine A (4),12, 13 verrucofortine (5),9, 12 cyclo-(L-Trp-L-Phe) (6),14, 15 cyclopenol (7),9, 16 cyclopenin (8),9, 17 penipratynolene (9),18, 19 aspterric acid (10)20 and viridicatol (11)16, 21 (Figure 1). Although the planar structure of penicyrones was found in the SciFinder as a compound in commercial chemical libraries, the stereostructure, spectroscopic data and origin were not available. We described herein the isolation of penicyrones A (1) and B (2) as secondary metabolites from the marine-derived Penicillium sp., structures including the absolute configurations of 1 and 2 and the anti-mycobacterial activity of verrucosidin (3). This is the first study to demonstrate that verrucosidin (3) exhibited inhibitory activity against Mycobacterium smegmatis.

Figure 1
figure 1

Structures of compounds 111 produced by the marine-derived fungus Penicillium sp. TPU1271.

Results and discussion

Structure elucidation

Compounds 311 were identified as verrucosidin, fructigenine A, verrucofortine, cyclo-(L-Trp-L-Phe), cyclopenol, cyclopenin, penipratynolene, aspterric acid and viridicatol, respectively (Figure 1), by comparing their spectroscopic data with the reported values.7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21

Penicyrones A (1) and B (2) were first obtained as a mixture by HPLC (octadecylsilyl (ODS)) with CH3OH-H2O (1:1). The mixture showed a clear 1H NMR spectrum; however, two sets of signals were detected for several carbons in the 13C NMR spectrum. The isolation of 1 and 2 was achieved by repeated HPLC (ODS) with CH3OH-H2O (2:3).

Compound 1 was isolated as a colorless oil. The MW and formula of 1, 434 and C24H34O7, respectively, were determined from the HRFABMS (high-resolution fast atom bombardment mass spectra) and NMR data. 1H and 13C NMR spectra showed 32 protons and 24 carbons (Table 1), which were classified into eight methyl, one oxygenated methyl, three sp3 oxygenated methine, three sp3 oxygenated quaternary, two sp2 methine, four sp2 quaternary, two sp2 oxygenated quaternary and one carbonyl carbons by an analysis of HMQC and DEPT spectra. The 1H NMR spectrum of 1 resembled that of verrucosidin (3), which suggested the presence of α-pyrone and tetrahydrofuran rings in 1. 1H-1H COSY data for 1 revealed two partial structures of C-15–C-16 and C-7–C-11 with C-21 and C-22. The connections of the two partial structures with α-pyrone and tetrahydrofuran rings were assigned by HMBC data for 1 (Figure 2). HMBC correlations were detected from H3-20 (δ 1.63) to C-5 (162.8), C-6 (75.3) and C-7 (133.8), from H-11 (5.70) to C-12 (81.7) and C-13 (68.9) and from H3-23 (1.33) to C-11 (130.3), C-12 and C-13. The NOESY correlations between H-7 (δ 5.88)/H-9 (δ 4.23), H-7/H3-20 (1.63), H-11 (5.70)/H-13 (3.55), H3-21 (1.33)/H3-22 (1.70) and H3-22/H3-23 (1.33) established the E-orientation of two double bonds at C-7 and C-10 (Figure 2). Thus, the planar structure of 1 was determined as shown in Figure 2.

Table 1 13C (100 MHz) and 1H (400 MHz) NMR data for penicyrones A (1) and B (2) in CD3OD
Figure 2
figure 2

1H-1H COSY, key HMBC and key NOESY correlations for penicyrones A (1) and B (2).

HRFABMS and NMR data for compound 2 revealed that the MW and formula (434, C24H34O7) of 2 were the same as those of 1. 1H and 13C NMR data for 2 were very similar to those for 1 (Table 1). Moreover, the 2D NMR spectra (1H-1H COSY, HMQC, HMBC and NOESY) of 2 showed the same correlations as those of 1. Therefore, the planar structure of 2 was elucidated to be the same as that of 1 (Figure 2).

This planar structure was found in the SciFinder as a commercially available reagent in chemical libraries for the screening of drug discovery. However, the origin, spectroscopic data and stereochemistry were not described. Consequently, this is the first study to isolate 1 and 2 as natural products from a fungal culture broth.

Absolute configurations of penicyrones A (1) and B (2)

NOE correlations between H-11 (1, δ 5.70; 2, δ 5.69)/H-13 (1, 3.55; 2, 5.54), H-13/H-24 (1, 1.43; 2, 1.42) and H-16 (1, 1.14; 2, 1.13)/H-24 observed in the NOESY spectra of 1 and 2 suggested that the relative configurations of 1 and 2 were the same as that of 3. As compounds 1 (+110.0), 2 (+96.0) and 3 (+70.0) showed similar specific rotations and were produced by the same fungal strain TPU1271 through the identical biogenetic pathway, the absolute configurations at the tetrahydrofuran ring (C-12–C-16) in 1 and 2 were assigned the same as those in 3. The absolute configuration of 3 was previously established by organic synthetic studies.22, 23, 24

Slight differences in 13C chemical shifts were detected for the signals due to C-7, C-8 and C-22, which indicated that 1 and 2 were the epimers of each other at the C-9 position. As NOESY data for 1 and 2 could not distinguish the configuration at C-9, 9-O-acetyl derivatives (1a and 2a) were prepared. The 1H NMR spectra of 1a and 2a showed marked differences in the chemical shifts at H-9 (1a, δ 5.32 and 2a, 5.30) and the acetyl methyl (1a, 2.05 and 2a, 2.02). NOESY data for 1a showed the correlations between H3-26 (δ 2.05)/H3-21 (1.39) and H3-26/H3-22 (1.76), and a correlation between H3-26 (2.02)/H3-20 (1.62) was observed in the NOESY spectrum of 2a. Based on the NOESY correlations, the most stable conformers of 9R and 9S isomers for O-acetyl derivatives were calculated by a Monte Carlo conformational analysis with an MMFF94 force field using Spartan’14. The stereostructures of the 9R isomer (Figure 3a) and 9S isomer (Figure 3b) agreed with the configurations of 1a and 2a, respectively. The configurations at the C-6 positions in 1 and 2 were assigned by the correlations between H-7 and H3-20 in the NOESY spectra of 1, 2, 1a and 2a.

Figure 3
figure 3

The calculated most stable conformers with key NOESY correlations for (a) 1a and (b) 2a. A full color version of this figure is available at The Journal of Antibiotics journal online.

Thus, the absolute configurations of 1 and 2 were elucidated as (6S, 9R, 12S, 13S, 14R, 15R) and (6S, 9S, 12S, 13S, 14R, 15R), respectively, as shown in Figure 1.

Biological activity

The anti-bacterial activities of compounds 111 against M. smegmatis NBRC 3207 were evaluated by the paper disc method.25, 26 Verrucosidin (3) showed an inhibition zone of 11 mm at 40 μg per disc. Compound 3 was initially isolated from Penicillium verrucosum var. cyclopium as a potent neurotoxin,7 and its inhibitory effects on GRP78 promoter expression has recently been reported.11 Consequently, this is the first study to demonstrate that verrucosidin (3) exhibited anti-mycobacterial activity. In spite of the structural similarities of 13, the two new compounds did not inhibit the growth of M. smegmatis.

Materials and methods

General experimental procedures

FABMS was performed using a JMS-MS 700 mass spectrometer (JEOL, Tokyo, Japan). 1H and 13C NMR spectra were recorded on a JNM-AL-400 NMR spectrometer (JEOL) at 400 MHz for 1H and 100 MHz for 13C in CD3OD (δH 3.31, δC 49.15). Optical rotations were measured with a JASCO P-2300 digital polarimeter (JASCO, Tokyo, Japan). UV spectra were obtained on a Hitachi U-3310 UV-Visible spectrophotometer (Hitachi, Tokyo, Japan) and IR spectra on a Perkin-Elmer Spectrum One Fourier transform infrared spectrometer (Perkin-Elmer, Waltham, MA, USA). CD spectra were measured with a spectrometer (J-720; JASCO). Secondary metabolites were analyzed by a LaChrom Elite HTA system (Hitachi). Preparative HPLC was conducted using a Toyosoda CCPU dual pump (Toyosoda Kogyo, Tokyo, Japan) with a Tosoh UV-8010 detector (Tosoh, Tokyo, Japan).

Materials

Potato dextrose agar, Middlebook 7H9 broth, polysorbate 80 and Middlebook OADC were purchased from BD (Franklin Lakes, NJ, USA). All other chemicals including organic solvents were purchased from Wako Pure Chemical Industries (Osaka, Japan).

Isolation and identification of strain TPU1271

The fungal strain TPU1271 was isolated from organic debris attached to a cultured oyster shell collected at a depth of 10 m in the Oshika Peninsula, Miyagi Prefecture, Japan, in June 2012. The debris was suspended in 25 ml of sterilized seawater, and 200 μl of the mixture was spread on an agar plate (potato dextrose agar, 90% seawater) and incubated at 25 °C. Strain TPU1271 was identified by the sequence of its ITS1 rDNA (231 nucleotides). Twenty-nine known Penicillium species including P. polonicum, P. cordubense and P. crustosum showed 100% identity, and, therefore, strain TPU1271 was identified as a Penicillium sp. The following sequence was used in a BLAST search: 5′-AGGTGAACCTGCGGAAGGATCATTACCGAGTGAGGGCCCTTTGGGTCCAACCTCCCACCCGTGTTTATTTTACCTTGTTGCTTCGGCGGGCCCGCCTTTACTGGCCGCCGGGGGGCTCACGCCCCCGGGCCCGCGCCCGCCGAAGACACCCCCGAACTCTGTCTGAAGATTGAAGTCTGAGTGAAAATATAAATTATTTAAAACTTTCAACAACGGATCTCTTGGTTCCGG-3′.

Fermentation

Strain TPU1271, which was grown on the potato dextrose agar plate, was inoculated into a 100-ml Erlenmeyer flask containing 40 ml of the seed medium (2.0% glucose, 0.5% polypeptone, 0.05% MgSO4·7H2O, 0.2% yeast extract, 0.1% KH2PO4, 0.1% agar in natural seawater; adjusted to pH 6.0 before sterilization). The flask was shaken reciprocally for 3 days at 25 °C to obtain the seed culture, which was then transferred to the production medium (3.0% sucrose, 3.0% soluble starch, 1.0% malt extract, 0.30% Ebios (Asahi Food and Healthcare, Tokyo, Japan), 0.50% KH2PO4 and 0.050% MgSO4·7H2O in natural seawater; adjusted to pH 6.0 before sterilization). The production culture was carried out at room temperature for 21 days under static conditions.

Extraction and isolation of compounds 1–11

Acetone (3.0 l) was added to the culture broth (3.0 l) after 21 days and filtered. The filtrate was concentrated to remove acetone, and the aqueous residue was adsorbed on an ODS column. The column was eluted stepwise with 10, 30, 40, 50, 60, 70, 80, 90 and 100% CH3OH in H2O for separation into nine fractions. Fr. 5 (171.4 mg, 60% CH3OH eluate) was separated by HPLC (column; PEGASIL ODS SP100 (Senshu Scientific, Tokyo, Japan), 10 × 250 mm2; mobile phase, 50% CH3OH; detection, UV at 210 nm; flow rate, 2.0 ml min−1) to give compounds 6 (2.1 mg), 8 (11.2 mg), 9 (2.4 mg) and 11 (5.5 mg), and a mixture of 1 and 2 (54.7 mg). Compounds 1 (5.5 mg) and 2 (4.1 mg) were purified from a portion of the mixture by repeated HPLC (PEGASIL ODS SP100, 40% CH3OH, UV 215 nm, 2.0 ml min−1, tR=~180 min). Compounds 4 (19.0 mg), 5 (2.6 mg) and 10 (80.5 mg) were isolated from Fr. 7 (161.0 mg, 80% CH3OH eluate) by HPLC (PEGASIL ODS SP100, 70% CH3OH, UV at 210 nm, 2.0 ml min−1). Compound 3 (17.5 mg) was obtained by HPLC (80% CH3OH) from Fr. 8 (70.5 mg, 90% CH3OH eluate). Fr. 3 (200.2 mg, 40% CH3OH eluate) was separated by a Sephadex LH-20 column (GE Healthcare UK Ltd., Buckinghamshire, UK) with 30% CH3OH to yield compound 7 (90.0 mg).

Penicyrone A ( 1): A colorless oil; [α]20D +110 (c 0.10, CH3OH); IR (KBr) νmax 3426, 2978, 2929, 2857, 1688, 1558, 1451, 1377, 1095, 1043 and 1012 cm−1; UV (CH3OH) λmax (nm) (log ɛ) 306 (3.40); CD (CH3OH) λextermum (nm) (Δɛ) 298 (+12.9), 213 (−40.9); HRFABMS m/z 435.2389 ([M+H]+; calcd for C24H35O7, 435.2383); 1H and 13C NMR (CD3OD) (see Table 1).

Penicyrone B ( 2): A colorless oil; [α]20D +96.0 (c 0.10, CH3OH); IR (KBr) νmax 3436, 2978, 2934, 2863, 1683, 1558, 1451, 1380, 1092, 1048 and 1026 cm−1; UV (CH3OH) λmax (nm) (log ɛ) 304 (3.63); CD (CH3OH) λextermum (nm) (Δɛ) 298 (+12.0), 213 (−38.8); HRFABMS m/z 435.2391 ([M+H]+; calcd for C24H35O7, 435.2383); 1H and 13C NMR (CD3OD) (see Table 1).

Verrucosidin ( 3): A pale yellow oil; [α]22D +70.0 (c 0.10, CH3OH); CD (CH3OH) λextermum (nm) (Δɛ) 291 (+1.48), 241 (+8.78); EIMS m/z 416 [M]+; 1H NMR (CD3OD): δ 5.83 (1H, s), 5.44 (1H, ts), 4.10 (1H, q, J=6.8 Hz), 3.80 (3H, s), 3.46 (1H, s), 3.40 (1H, s), 2.02 (3H, s), 2.01 (3H, s), 1.93 (3H, brs), 1.87 (3H, brs), 1.44 (3H, s), 1.40 (3H, s), 1.39 (3H, s) and 1.16 (3H, d, J=6.8 Hz).

Preparation of 9-O-acetyl penicyrones A (1a) and B (2a)

Acetic anhydride (2.0 μl, 21 nmol), pyridine (2.0 μl, 25 nmol) and 4-(dimethylamino)pyridine (0.1 mg, 0.83 nmol) were added to a solution of compound 1 (2.0 mg, 4.6 nmol) in CH2Cl2 (100 μl), and the solution was stirred at room temperature for 10 h. The reaction mixture was evaporated in vacuo, dissolved in water and extracted with EtOAc. The organic layer was concentrated in vacuo to give 9-O-acetyl-penicyrone A (1a, 1.66 mg, 3.5 mmol, 76.1%). The purity of the product was sufficient for NMR experiments.

9-O-Acetyl-penicyrone B (2a, 1.73 mg, 3.6 mmol, 78.3%) was prepared by similar procedures as described above.

9-O-Acetyl-penicyrone A ( 1a): A colorless oil; [α]21D +122 (c 0.10, CH3OH); IR (KBr) νmax 3434, 2973, 2929, 1739, 1714, 1690, 1561, 1454, 1372, 1355, 1237, 1089, 1043 and 1029 cm−1; UV (CH3OH) λmax (nm) (log ɛ) 300 (3.97); CD (CH3OH) λextermum (nm) (Δɛ) 297 (+10.9), 213 (−33.5); HRFABMS m/z 477.2492 ([M+H]+; calcd for C26H37O8, 477.2488); 1H NMR (CD3OD): δ 5.84 (1H, t, J=0.9 Hz, H-7), 5.65 (1H, t, J=0.9 Hz, H-11), 5.32 (1H, s, H-9), 4.02 (1H, q, J=6.8 Hz, H-15), 3.85 (3H, s, H-18), 3.54 (1H, s, H-13), 2.08 (3H, s, H-19), 2.05 (3H, s, H-26), 2.02 (3H, s, H-17), 1.76 (3H, br d, J=0.7 Hz, H-22), 1.61 (3H, s, H-20), 1.41 (3H, s, H-24), 1.39 (3H, br d, J=1.0 Hz, H-21), 1.30 (3H, s, H-23) and 1.11 (3H, d, J=6.8 Hz, H-16).

9-O-Acetyl-penicyrone B ( 2a): A colorless oil; [α]21D +118 (c 0.10, CH3OH); IR (KBr) νmax 3432, 2978, 2934, 1742, 1714, 1690, 1561, 1451, 1372, 1353, 1235, 1089, 1078, 1040 and 1026 cm−1; UV (CH3OH) λmax (nm) (log ɛ) 297 (3.85); CD (CH3OH) λextermum (nm) (Δɛ) 297 (+13.8), 213 (−41.2); HRFABMS m/z 477.2498 ([M+H]+; calcd for C26H37O8, 477.2488); 1H NMR (CD3OD): 5.82 (1H, t, J=0.9 Hz, H-7), 5.67 (1H, t, J=0.9 Hz, H-11), 5.30 (1H, s, H-9), 4.02 (1H, q, J=6.8 Hz, H-15), 3.85 (3H, s, H-18), 3.55 (1H, s, H-13), 2.08 (3H, s, H-19), 2.024 (3H, s, H-26), 2.020 (3H, s, H-17), 1.76 (3H, br d, J=0.7 Hz, H-22), 1.62 (3H, s, H-20), 1.42 (3H, s, H-24), 1.38 (3H, br d, J=1.0 Hz, H-21), 1.30 (3H, s, H-23) and 1.11 (3H, d, J=6.8 Hz, H-16).

Conformational analysis

The most stable conformers of 1a and 2a were predicted using Spartan’14 (Wavefunction, Irvine, CA, USA) by a preliminary conformational analysis with the MMFF94 force field followed by geometry optimization using the density functional theory with the B3LYP functional and 6-31G* basis set.

Anti-microbial assay

An anti-bacterial assay was carried out using M. smegmatis NBRC 3207 by the paper disc method.25, 26 Strain NBRC 3207 was obtained from the Biological Resource Center (NBRC) and NITE (Chiba, Japan), and maintained in 20% glycerol at −80 °C.

The test microorganism was cultured in Middlebook 7H9 broth containing 0.05% polysorbate 80, 0.5% glycerol and 10% Middlebook OADC at 37 °C for 2 days and adjusted to 1.0 × 106 CFU ml−1. The inoculum was spread on the above medium containing 1.5% agar in a square plate. Each sample in CH3OH was adsorbed to a sterile filter disc (6 mm; Advantec, Tokyo, Japan), and, after the evaporation of CH3OH, the disc was placed on an agar plate and incubated for 2 days at 37 °C. Streptomycin sulfate and CH3OH were used as positive and negative controls, respectively.